Atlas Trials

SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation

Clinical trial NCT04631705 · TERMINATED

Trial details

NCT number
NCT04631705
Sponsor
University of Cologne
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
SARS-CoV-2 Infection
Start date
2020-12-14
Primary completion
2021-09-23
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.